Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System

NCT00068666 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00068666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00068666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2004
Completion date
March 31, 2010
Enrollment
41 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin), metastatic cancer